CMCR Grants Program - 2020 - Submission is now Closed
The Center for Medicinal Cannabis Research (CMCR) seeks to fund primary and pilot cannabis-related studies that further enhance the understanding of the efficacy and adverse effects of cannabis and cannabinoids as pharmacological agents for the treatment of medical and psychiatric disorders, and their potential public health impacts. Primary project awards are up to $825,000 in total costs ($275,000 per year) for up to three years. Pilot awards are up to $300,000 for two years ($150,000 per year). Priority is given to proposals addressing issues identified under Funding Priorities.
Funding priorities include studies that 1) provide proof-of-principle findings that inform future, more comprehensive studies, 2) address scientific gaps identified by authoritative reviews (e.g., ‘The Health Effects of Cannabis and Cannabinoids’, National Academy of Sciences, Engineering, and Medicine; 2017), or 3) represent promising new directions for research. Studies may address both beneficial and harmful effects of cannabis (e.g., effects on cognition, driving).
Examples of areas of emphasis include, but are not limited to:
• Pain, particularly potential opioid-sparing effects
• Movement disorders
• Autoimmune disorders (e.g., inflammatory bowel disease)
• Sleep disorders
• Traumatic brain injury
• Post-traumatic stress disorder
• Anxiety disorders
• Weight loss due to chronic medical conditions
• Autism spectrum disorder
• Early psychosis
• Anorexia nervosa
• Impacts in older adults
• Cardiovascular effects
• Role of minor cannabinoids in human health
• Basic science and animal studies with clear translational implications for human health and disease
• Assays/methods for detection of cannabinoids, endocannabinoids, related substances
• Public safety
CMCR anticipates issuing a call for new applications in 2021. Check our website for future announcements.